Fortis Healthcare Ltd Share Price – NSE /  BSE

Healthcare, Small Cap

Fortis Healthcare announced that its wholly owned subsidiary, International Hospital on 19 December 2025 has signed definitive agreements for acquisition of TMI Healthcare (primarily comprises hospital operations) through a share purchase agreement and acquisition of the underlying hospital land and building, and the adjacent land thereto (Proposed Transaction).

The acquisition will enable the company to expand, scale up and deliver quality healthcare services to patients in Bengaluru.

TMI Healthcare comprises the People Tree Hospital, Yeshwanthpur and two identified facilities (People Tree Hospital, Raghavendra and People Tree Hospital, Meenakshi). As part of the transaction to acquire 100% equity stake in TMI Healthcare; the above identified facilities would be carved out from TMI Healthcare prior to transaction closure.

In addition to the acquisition of TMI Healthcare, IHL is also acquiring the underlying land and hospital building and an adjacent land parcel.

Powered by Capital Market - Live News

Fortis Healthcare on 20 December 2025 announced plans to invest around Rs 840 crore to expand its footprint in Bengaluru, as part of its cluster focused growth strategy in the city.

The company said it has signed definitive agreements to acquire the 125 bedded People Tree Hospital in Yeshwanthpur through its wholly owned subsidiary, International Hospital. The composite transaction, including the acquisition of the hospital business, building and land, is valued at Rs 430 crore, including debt.

Fortis will also acquire an adjacent land parcel of around 0.8 acres, which will allow the facility to scale up to more than 300 beds. An additional investment of about Rs 410 crore is planned over the next three years to expand bed capacity, upgrade medical equipment and add clinical programmes such as radiation oncology.

People Tree Hospital Yeshwanthpur is a NABH accredited multi specialty facility offering services across cardiac sciences, orthopaedics, neurosciences, renal sciences and gastroenterology. Based on current revenues of about Rs 74 crore in FY25, Fortis said it sees scope to improve utilisation, revenues and profitability while executing the expansion.

The transaction is expected to be completed by the end of January 2026, subject to customary conditions. With this acquisition, Fortis said its Bengaluru network has the potential to scale up to over 1,500 beds across seven facilities over the next three years, from about 900 beds at present.

Fortis Healthcare is a leading integrated healthcare delivery service provider in India. The healthcare verticals of the company primarily comprise hospitals, diagnostics and day care specialty facilities. Currently, the company operates 33 healthcare facilities (including JVs and O&M facilities) across 11 states. The company's network comprises approximately 5,800 operational beds (including O&M beds) and over 400 diagnostics labs.

On a consolidated basis, Fortis Healthcare's net profit rose 82.43% to Rs 321.92 crore while net sales rose 17.25% to Rs 2331.44 crore in Q2 September 2025 over Q2 September 2024.

Shares of Fortis Healthcare rose 2.80% to settle at Rs 890.65 on Friday, 19 December 2025.

Powered by Capital Market - Live News

Net profit of Fortis Healthcare rose 82.43% to Rs 321.92 crore in the quarter ended September 2025 as against Rs 176.46 crore during the previous quarter ended September 2024. Sales rose 17.25% to Rs 2331.44 crore in the quarter ended September 2025 as against Rs 1988.39 crore during the previous quarter ended September 2024.

Powered by Capital Market - Live News

Fortis Healthcare will hold a meeting of the Board of Directors of the Company on 11 November 2025.

Powered by Capital Market - Live News